Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Given superior weight loss and comorbidity impact, analysts expect multi-agonists to exceed 45% of the anti-obesity drugs market by 2031
But some companies really took a gamble and said, let's see if these drugs GLP-1 in particular can really be used for obesity
With the development of genetic testing technologies such as genome-wide association studies (GWAS) and next-generation sequencing (NGS), it has been discovered that approximately 127 locus abnormalities in the human genome are associated with the onset and progression of obesity [4] , as along with more than 550 monogenic mutations related to obesity [5]
Scientifically, they work by mimicking a natural hormone in your body called glucagon-like peptide-1, which is released in the gut after you eat
US$ 27.33
US$ 21.15
US$ 20.34
US$ 29.54
US$ 28.27
US$ 24.41
US$ 22.23
